LDB2 and atherosclerosis: The Stockholm Atherosclerosis Gene Expression (STAGE) study involved from 2009 performed whole-genome transcriptome analyses in five tissues and identified an atherosclerosis module that included LIM domain-binding protein 2 (LDB2) as a high-hierarchy regulator [9].